Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Guidelines for protocol studies in chronic lymphocytic leukemia

R T Silver, A Sawitsky, K Rai

    American Journal of Hematology
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The bone marrow of normal cats.

    The Journal of laboratory and clinical medicine·2010
    Same author

    Prevalence of HTLV-I-associated T-cell lymphoma.

    American journal of hematology·2001
    Same author

    Coagulation abnormalities in patients with Gaucher's disease: effect of therapy.

    American journal of hematology·1996
    Same author

    Impaired interferon alpha response in hairy cell leukemia is corrected by therapy with 2-chloro-2'-deoxyadenosine: implications for susceptibility to opportunistic infections.

    Leukemia·1994
    Same author

    Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line.

    Proceedings of the National Academy of Sciences of the United States of America·1992
    Same author

    Successful successive studies in leukemia and breast cancer.

    The Mount Sinai journal of medicine, New York·1992
    Same journal

    EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia.

    American journal of hematology·2026
    Same journal

    Subtotal Versus Total Splenectomy in Children With Sickle Cell Disease: Clinical Outcomes and Splenic Function Assessed by Pocked Red Blood Cell Count.

    American journal of hematology·2026
    Same journal

    High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1.

    American journal of hematology·2026
    Same journal

    Peripheral Blood Lymphocytosis Reflecting an Underlying Thymoma.

    American journal of hematology·2026
    Same journal

    Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children.

    American journal of hematology·2026
    Same journal

    Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk-Stratification and Management.

    American journal of hematology·2026
    See all related articles

    New guidelines for chronic lymphocytic leukemia (CLL) studies offer updated diagnostic and treatment response evaluation criteria. These Cancer and Leukemia Group B protocols aim to advance CLL research and clinical practice for investigators worldwide.

    Area of Science:

    • Hematology
    • Oncology
    • Clinical Trial Design

    Background:

    • Effective treatment of malignant diseases necessitates robust diagnostic criteria, study methodologies, and response evaluation techniques.
    • Recent years have seen the development of several proposed guidelines for chronic lymphocytic leukemia (CLL) research.

    Purpose of the Study:

    • To present a re-evaluated set of guidelines for chronic lymphocytic leukemia (CLL) studies.
    • To provide a framework for current and future research in CLL, facilitating consistent and comparable results.

    Main Methods:

    • The guidelines incorporate updated concepts and methodologies for CLL research.
    • These standards are currently implemented in protocol studies by the Cancer and Leukemia Group B.

    Related Experiment Videos

    Main Results:

    • The proposed guidelines offer a refined approach to the study of chronic lymphocytic leukemia (CLL).
    • Adoption by the Cancer and Leukemia Group B signifies their practical utility in ongoing research.

    Conclusions:

    • These guidelines represent a significant advancement in the study of chronic lymphocytic leukemia (CLL).
    • Continuous revision is anticipated as scientific knowledge evolves, ensuring the guidelines remain current.
    • Publication is intended to promote widespread adoption and collaboration among investigators in the field of CLL research.